CLINICAL_TRIALS
trial_result
· 2013-03-14
Clinical Trial Update: NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation [Phase 3]
Summary
Phase 3 clinical trial evaluating the NAVISTAR ThermoCool catheter for radiofrequency ablation of symptomatic paroxysmal atrial fibrillation has completed with …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biosense Webster, Inc. | Conditions: Heart Diseases, Arrhythmia | Phase 3 | Status: COMPLETED | Results posted: 2013-03-14